Rockefeller Capital Management L.P. bought a new position in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 266,467 shares of the company's stock, valued at approximately $10,043,000. Rockefeller Capital Management L.P. owned approximately 0.61% of Vital Farms as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Wellington Management Group LLP increased its position in Vital Farms by 417.8% in the fourth quarter. Wellington Management Group LLP now owns 2,431,024 shares of the company's stock worth $91,625,000 after buying an additional 1,961,550 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Vital Farms by 78.7% in the 4th quarter. Principal Financial Group Inc. now owns 1,171,950 shares of the company's stock worth $44,172,000 after acquiring an additional 516,139 shares during the last quarter. Jupiter Asset Management Ltd. increased its holdings in Vital Farms by 96.3% in the 4th quarter. Jupiter Asset Management Ltd. now owns 628,709 shares of the company's stock worth $23,696,000 after acquiring an additional 308,425 shares during the last quarter. Pictet Asset Management Holding SA raised its stake in Vital Farms by 30.0% in the 4th quarter. Pictet Asset Management Holding SA now owns 905,354 shares of the company's stock valued at $34,123,000 after acquiring an additional 208,951 shares during the period. Finally, Emerald Advisers LLC lifted its holdings in Vital Farms by 22.3% during the fourth quarter. Emerald Advisers LLC now owns 864,323 shares of the company's stock valued at $32,576,000 after purchasing an additional 157,883 shares during the last quarter. Hedge funds and other institutional investors own 98.59% of the company's stock.
Analyst Ratings Changes
Several research firms have recently issued reports on VITL. William Blair reissued an "outperform" rating on shares of Vital Farms in a research report on Friday, February 28th. TD Cowen boosted their target price on shares of Vital Farms from $41.00 to $45.00 and gave the company a "buy" rating in a report on Wednesday, January 8th. Morgan Stanley dropped their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Telsey Advisory Group reiterated an "outperform" rating and issued a $52.00 price target on shares of Vital Farms in a research report on Thursday, March 13th. Finally, Stifel Nicolaus raised Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective on the stock in a report on Friday, February 28th. Nine research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $43.13.
View Our Latest Report on VITL
Insider Transactions at Vital Farms
In related news, CEO Russell Diez-Canseco sold 45,124 shares of the firm's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the transaction, the chief executive officer now directly owns 703,736 shares of the company's stock, valued at approximately $23,708,865.84. This trade represents a 6.03 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Matthew Ohayer sold 4,000 shares of the company's stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $31.39, for a total value of $125,560.00. Following the completion of the sale, the insider now directly owns 6,966,890 shares of the company's stock, valued at approximately $218,690,677.10. This represents a 0.06 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 69,124 shares of company stock valued at $2,234,988. Insiders own 27.60% of the company's stock.
Vital Farms Price Performance
Shares of VITL stock traded up $0.43 on Tuesday, reaching $33.49. The company's stock had a trading volume of 608,502 shares, compared to its average volume of 1,040,232. The company has a market capitalization of $1.48 billion, a P/E ratio of 29.90 and a beta of 0.96. Vital Farms, Inc. has a 12-month low of $24.87 and a 12-month high of $48.41. The stock's 50 day simple moving average is $32.23 and its 200-day simple moving average is $35.49. The company has a quick ratio of 2.81, a current ratio of 3.24 and a debt-to-equity ratio of 0.04.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.15 by $0.08. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The company had revenue of $165.99 million during the quarter, compared to analyst estimates of $160.32 million. As a group, equities analysts predict that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.
Vital Farms Company Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Stories

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.